Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Advances in Immunology
|
January 1, 1980
The virology and immunobiology of lymphocytic choriomeningitis virus infection
M J Buchmeier, R M Welsh, F J Dutko, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1993
Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection
R B Turner, F J Dutko, N H Goldstein, et al.
Journal of Virology
|
March 1, 1985
The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2
Y Riviere, R Ahmed, P J Southern, et al.
Journal of Medicinal Chemistry
|
March 20, 1992
CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14
G D Diana, P Kowalczyk, A M Treasurywala, et al.
Journal of Virology
|
April 1, 1980
Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus?
M B Oldstone, A Tishon, F J Dutko, et al.
Pharmaceutical Research
|
January 1, 1992
Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound
S A Charman, W N Charman, M C Rogge, et al.
Journal of Medicinal Chemistry
|
September 3, 1993
Keto/enol epoxy steroids: a new structural class of HIV-1 Tat inhibitors
W F Michne, J D Schroeder, T R Bailey, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1992
Drugs as molecular tools
F J Dutko, D E Baright, G D Diana, et al.
Journal of Medicinal Chemistry
|
May 1, 1990
A model for compounds active against human rhinovirus-14 based on X-ray crystallography data
G D Diana, A M Treasurywala, T R Bailey, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1989
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug
M G Woods, G D Diana, M C Rogge, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Advances in Immunology
|
January 1, 1980
The virology and immunobiology of lymphocytic choriomeningitis virus infection
M J Buchmeier, R M Welsh, F J Dutko, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1993
Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection
R B Turner, F J Dutko, N H Goldstein, et al.
Journal of Virology
|
March 1, 1985
The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2
Y Riviere, R Ahmed, P J Southern, et al.
Journal of Medicinal Chemistry
|
March 20, 1992
CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14
G D Diana, P Kowalczyk, A M Treasurywala, et al.
Journal of Virology
|
April 1, 1980
Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus?
M B Oldstone, A Tishon, F J Dutko, et al.
Pharmaceutical Research
|
January 1, 1992
Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound
S A Charman, W N Charman, M C Rogge, et al.
Journal of Medicinal Chemistry
|
September 3, 1993
Keto/enol epoxy steroids: a new structural class of HIV-1 Tat inhibitors
W F Michne, J D Schroeder, T R Bailey, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1992
Drugs as molecular tools
F J Dutko, D E Baright, G D Diana, et al.
Journal of Medicinal Chemistry
|
May 1, 1990
A model for compounds active against human rhinovirus-14 based on X-ray crystallography data
G D Diana, A M Treasurywala, T R Bailey, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1989
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug
M G Woods, G D Diana, M C Rogge, et al.
Page
of 4